(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ZUMUTOR BIOLOGICS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ZUMUTOR BIOLOGICS

ST13

US500000086921165

Class

42

Filing

86921165

Registration

5324646

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

10/05/2023

Trademark type

Word

Nice classes

42

Filing date

02/26/2016

Registration date

10/31/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/05/2023

Last transaction

10/05/2023

Responsible office

United States Patent and Trademark Office

Status code

701

Official register

Principal Register

First use anywhere

06/22/2015

First use in commerce

08/01/2016

Drawing code

4

Owner type

03

Owner location

Cambridge, MA

Examiner

FOSDICK, GEOFFREY

Law office

M20

Current location

TMO LAW OFFICE 111

Holders and representatives

Holders

Zumutor Biologics Inc
Zumutor Biologics Inc

Representatives

Zumutor Biologics Inc

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Bacteriological research; Biochemical research and development; Biological research; Biotechnology research; Chemicalbiochemicalbiological and bacteriological research and analysis; Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Medical research services in the field of cancer; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research and development; Pharmaceutical research services; Product development consultation; Product development for others; Product research; Research and development of vaccines and medicines; Research in the field of chemistry; Research on the subject of pharmaceuticals; Scientific research consulting in the field of oncologyrheumatoid arthritisdiabetes and metabolic disorders; Scientific research for medical purposes in the field of oncologyrheumatoid arthritisdiabetes and metabolic disorders; Scientific research in the field of genetics and genetic engineering; Testinginspectionresearchdevelopment of pharmaceutical preparations for gene therapy

Publications

History of USPTO decisions and trademark events.

28 publications found

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

10/05/2023

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

10/05/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/05/2023

ES8R

TEAS SECTION 8 RECEIVED

05/26/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

10/31/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

10/31/2017

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

09/27/2017

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

09/26/2017

SUPC

STATEMENT OF USE PROCESSING COMPLETE

09/20/2017

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

09/14/2017

IUAF

USE AMENDMENT FILED

08/28/2017

EISU

TEAS STATEMENT OF USE RECEIVED

08/28/2017

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/28/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/03/2017

PUBO

PUBLISHED FOR OPPOSITION

01/03/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/14/2016

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

11/29/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/23/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/22/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/22/2016

ALIE

ASSIGNED TO LIE

11/08/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/28/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/10/2016

GNRT

NON-FINAL ACTION E-MAILED

06/10/2016

CNRT

NON-FINAL ACTION WRITTEN

06/10/2016

DOCK

ASSIGNED TO EXAMINER

06/10/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/02/2016

NWAP

NEW APPLICATION ENTERED

03/01/2016

Continuous trademark protection

Get notified about every new filing that threatens ZUMUTOR BIOLOGICS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.